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Absract
Background: Diabetes mellitus (DM) causes serious complications such as coronary heart disease, atherosclerosis, nephropathy, retinopathy
and neuropathy.
Materials and Methods: Rats were randomly divided into three groups, each containing 10 rats: control group, DM group; DM+crocin group.
Normal saline was administered in the control and DM groups, and crocin was administered in DM+crocin group at a dose of 20 mg/kg bw/day
for 21 days. Trunk blood and the hearth tissue were collected for histopathological and biochemical examination.
Results: DM led to increment of MDA levels (p<0.05) and the serum levels of total cholesterol, TG, LDL and VLDL (p<0.05) and decrease of
GSH levels (p<0.01) compared to control group in serum and heart tissue. Diabetic rats were treated with crocin, MDA levels (p<0.05) and the
levels of total cholesterol, TG and VLDL decreased significantly, but GSH levels (p<0.05) increased remarkably compared to DM rats.
Statistically significant increase in histopathological damage score was found in the DM group (p<0.0001). Histopathological changes markedly
regressed in DM+crocin group.
Conclusion: Our results showed that crocin might prevent diabetes induced cardiovascular complications by reduction of oxidative stress and
dyslipidemia.
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Introduction
Diabetes mellitus (DM) is a chronic disorder of carbohydrate, fat and protein metabolism characterized by high level of glucose in the
blood due to the absence of insulin secretion from β cells or insulin insensitivity (Vardi et al., 2003). DM causes serious complications such as
coronary heart disease, atherosclerosis, nephropathy, retinopathy and neuropathy (Militante et al., 2000).
Coronary artery disease is one of the major complications of oxidative stress (Samarghandian et al., 2014). It has been shown that
patients with diabetes have the greater risk of cardiovascular diseases (Wang and Reusch, 2012). Previous studies have demonstrated that both
type 1 and type 2 diabetes lead to increase in oxidative stress and depletion of antioxidant defense systems due to elevated formation of free
radicals (Rahimi et al., 2005).
Oxidative stress results from an imbalance of oxidants/antioxidants in favour of oxidants. The generation of free oxygen radicals and
Reactive Oxygen Species (ROS) causes oxidative stress. ROS have toxic effects on all components of the cell, including protein, lipid, DNA and
particularly cell membrane in which they react with membrane phospholipids and cause to production of lipid peroxidation (Bast et al., 1991).
ROS play an important role in the pathogenesis of many complications such as hypoxia, hypercholesterolemia, hypertension, ischemia
reperfusion injury, atherosclerosis and heart failure (Wilcox and Gutterman, 2005).
Malondialdehyde (MDA), a biomarker for oxidative stress, is generated endogenously by lipid peroxidation (Esterbauer, 1993). It has
been shown that glutathione (GSH) deficiency is associated with pathophysiology of many diseases including cancer, neurodegenerative and
cardiovascular diseases (Cotgreave and Gerdes, 1998).
Saffron is the dried stigma of Crocus Sativus L. and is used in medicine for treatment of cancer and mental disorders (Fratelli et al.,
2002). Saffron contains three main pharmacologically active metabolities. They are crocins, which are unusual water-soluble carotenoids (mono
and diglycosyl esters of a polyene dicarboxylic acid, named crocetin); picrocrocin and safranal (Srivastava et al., 2010). It has been shown that
saffron and its active constituents have a wide variety of pharmacological effects such as antigenotoxic, neuroprotective, analgesic,
antihypertensive, antihyperlipidemic and anti-inflammatory effects (Farahmand et al., 2013).
In addition, saffron, crocin, crocetin and safranal have high antioxidant activity by scavenging free radicals (Chen et al., 2008).
Antidiabetic drugs do not effectively provide protection against complications of diabetes such as oxidative stress (Gilbert and Pratley, 2009).
Thus, studies that focused on plant originating antioxidants are getting more popular. Crocetin is capable of increasing insulin
sensitivity and preventing complications associated with insulin resistance such as disrupted glucose tolerance, dyslipidemia, hyperinsulinemia
and hypertension due to high fructose diet and dexamethasone injection in rats (Xi et al., 2007).
In addition, crocetin inhibited adhesion of leukocytes to the bovine aortic endothelial cells (BEC) (Xiang et al., 2006b). Dyslipidemia
is a condition which levels of blood lipid fractions are dysregulated (Bhalodia et al., 2010). Blood lipids usually increase in DM and play an
important role in coronary artery disease. Diabetes and hypercholesterolemia are the main reasons of endothelial dysfunction (Kolluru et al.,
2012).
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The aim of this study was to determine the effects of crocin on cardiovascular complication, dyslipidemia and oxidative stress by
measuring MDA and GSH levels in serum and heart tissue as well as serum lipid levels in streptozotocin induced diabetic rats.
Materıal and Methods 
Experimental Animals
In this study, 30 female Wistar rats weighing 170-200 g were obtained from the Inonu University Faculty of Medicine – Experimental
Research Department. Animals were housed in colony rooms with 12/12 h light/dark cycle at 21°C, 55-60 % humidity and fed with rat, cow and
given water ad libitum. The experimental protocol was evaluated and approved by the Ethics Review Committee of Inonu University, Faculty of
Medicine, Malatya, Turkey.
Experimental Design
At the onset of the study, a blood sample was taken from tail vein of each rat for the measuremant of blood glucose levels. Rats were
randomly divided into three groups each containing 10 rats as follows; group 1, control (nondiabetic rats); group 2, DM (STZ-induced untreated
diabetic rats); grup 3, DM+crocin (STZ-induced diabetic rats treated with crocin,).
Streptozotocin (STZ;Sigma Chemical Co., St. Louis, MO, USA) which was dissolved in 0.01 M sodium citrate buffer (pH 4.5) was
injected intraperitoneally (i.p.) at a single dose of 50 mg/kg body weight (bw) in DM and DM+crocin groups. 1 mL citrate buffer alone was
injected i.p. in control group. After 3 days of STZ administration, blood glucose levels from tail vein were measured using reagent strip (Accu-
Check Active Glucose test strips, ROCHE, Germany) with glucometer (Accu-Check Active, ROCHE, Germany).
Blood glucose levels of control group were in normal levels. STZ and STZ+crocin groups were accepted as diabetic because blood
glucose levels were above 270 mg/dL. Normal saline was administered in the control and DM groups, and crocin (Sigma Chemical Co., St.
Louis, MO, USA.) dissolved in normal saline was administered at a dose of 20 mg/kg bw/day (Zheng et al., 2007). All adminstrations were
performed at the same hour and with a volume of 5 mL/kg bw/day by gavage and continued for 21 days. At the end of the study, all rats were
decapitated under the xylazine (Bayer Birlesik Alman I˙lac¸ Fabrikalari T.A.S., Istanbul, Turkey) and ketamine (Parke Davis, Istanbul, Turkey ) 
anesthesia at the dose of 10 mg/kg and 50 mg/kg respectively. Trunk blood was collected for measuring GSH, MDA and lipid levels of serum.
The heart tissue was removed rapidly and divided into two equal pieces. One of the pieces was placed into 10% formaldehyde for
routine histopathological examination. The other piece was stored at -80 °C for the measurement of MDA and GSH levels.
Biochemical Analysis
Measurement of Serum Lipid Profile
Blood samples for the measurement of serum lipids were extracted to determine drawn into tubes and immediately placed on ice. All
tubes were centrifuged within several minutes of collection. The levels of triglycerides (TG), total cholesterol, low-density lipoprotein (LDL),
very-low density lipoprotein (VLDL) and high-density lipoprotein (HDL) in serum were performed by using commercially available Architect c
1600 automatic analyzer kits (Abbott, Abbott Park, Illinois, USA). Results were expressed as mg/dL.
Measurement of Serum MDA Levels
The formation of MDA was measured in the serum. The main principle of the analysis is based on the fact that MDA in the medium
reacts when heated with thiobarbituric acid and creates a pink chromogen. The intensity of the pink color is in direct proportion to MDA
concentration. MDA levels were assayed spectrophotometrically at 535 nm according to the method described by Ohkawa et al (Ohkawa et al.,
1979). Results were expressed as µmol/L.
Measurement of Serum GSH Levels
GSH levels were measured by the method followed by Ellman (Ellman, 1959). GSH is reacted with 5,5-dithiobis-2- nitrobenzoic acid
resulting in the formation of a product which has a maximal absorbance at 410 nm. Results were expressed as µmol/L.
Measurement of Heart MDA and GSH Levels
The heart tissue was homogenized in ice within 10 volumes (w/v) of 0.1 M Tris (hydroxymethyl) aminomethane–hydrochloric acid
buffer (pH 7.5; includes protease inhibitor, phenylmethylsulfonyl fluoride, 1 mM) via homogenizer (IKA Ultra Turrax T25 basic, IKA
Labotechnik, Staufen, Germany) at 16,000 r/min and at +4 °C for 3 min. The supernatants were used for the measurement of MDA and GSH
levels. The results of heart tissue were expressed as nanomoles per gram wet tissue.
Histological Determination
Heart tissues were fixed in 10% formalin and were embedded in paraffin. The 5 μm sections were stained with hematoxylin-eosin (H-
E) and examined for severity of cardiac damage such as hemorrhage, vacuolization, infiltration and loss of myofibril in 10 different fields for
each section. For this analysis, cardiac damage was semiquantitatively graded as absent (0), mild (1), moderate (2), and severe (3), for each
criterion. The maximum histopathological damage score was 12. All sections were examined using a Leica DFC280 light microscope and a
Leica Q Win and Image Analysis system (Leica Micros Imaging Solutions Ltd., Cambridge, UK).




Data were analyzed using Statistical Package for Social Sciences for Windows version 13.0 (SPSS Inc., Chicago, Illinois, USA)
statistical program. Histopathological and biochemical results were expressed as mean±SD. Normality for continued variables in groups was
determined by the Shapiro–Wilk test. The variables did not show normal distribution ( p < 0.05). Kruskal–Wallis and Mann–Whitney U tests
were used for comparison of variables among the studied groups. The value of p < 0.05 was considered statistically significant.
Results
Table 1 presents the levels of MDA and GSH in the serum and the heart tissue respectively. Briefly, DM led to increment of MDA
levels (p<0.05) and decrease of GSH levels (p<0.01) compared to control group. When diabetic rats were treated with crocin, MDA levels
(p<0.05) decreased significantly, but GSH levels (p<0.05) increased remarkably compared to DM rats. Furthermore, MDA and GSH levels
(p<0.05) were close to control group values through the effect of crocin.







(µmol/L) (nmol/g wet tissue) (nmol/g wet tissue)
Control 166±16 136±21 166±9 270±38
DM 312±45a 106±68c 264±13d 164±19d
DM + Crocin 235±27b 126±30b 183±7e 264±21e,c
Values are expressed as mean±SD. ap<0.05 vs control rats; bp<0.05 vs diabetic rats; cp<0.01 vs control rats; dp<0.01 vs control rats; ep<0.05 vs
control rats.
Table 2 presents serum lipid levels of all groups. Diabetes caused significant increase serum total cholesterol, TG, LDL and VLDL
(p<0.05) levels when compared to control group. However, HDL did not decrease significantly in DM group. After diabetic rats were treated
with crocin, total cholesterol, TG and VLDL levels decreased remarkably, but LDL did not decrease significantly. Also, HDL did not increase
remarkably in DM+crocin group.











Control 45±1.5 66±8 11±1.6 13±1.6 20±0.9
DM 59±2.1a 102±12a 18±6.1a 23±3.7a 18±0.8
DM + Crocin 46±6.2b 60±10b 16±2.2 12±2.1b 21±1
Values are expressed as mean±SD. ap<0.05 vs control rats; bp<0.05 vs diabetic rats.
The heart tissue in the control group was normal in histological appearance (Figure 1A). However, in the DM group, extensive
hemorrhagic areas (Figures 1B, 1D), cytoplasmic and perinuclear myocardial vacuolization (Figures 1C, 1D), common inflammatory of cells
(Figure 1E) and additionally in some areas, loss of myofibril (Figure 1F) were detected. Statistically significant increase in histopathological
damage score was found in the DM group when compared to the control group (p<0.0001). On the other hand, these histopathological changes
markedly regressed in DM+crocin group (Figures 1G, H). When DM group and DM+crocin group were compared, a statistically significant
difference was detected (p<0.001). The histopathological damage score for each group was given in Table 3.










Data are expressed arithmetic mean±SE of animals.
a P <0.0001 vs group 1. b P <0.001 vs group 2.
Discussion
The main results of the present study demonstrate that crocin treatment significantly ameliorates oxidative stress and elevates lipid
profile in diabetic rats.
This is the first histological and biochemical study evaluating the effects of crocin on STZ-induced cardiac complication. In the present
study, we have found that crocin has protective effect against oxidative stress in serum and heart tissue of STZ-induced diabetic rats. STZ
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administration led to decrease in GSH levels of serum and heart tissue, accompanied by a significant increase in MDA levels of serum and heart
tissue. Also, STZ-induced DM caused to increase in serum lipid profiles.
Figure 1: A. Histological appearence was normal in control group. H-E; X40. B. Extensive hemorrhagic area (star) was observed in DM group.
H-E; X20. C. Myocardial vacuolization (arrows) was detected in DM group. H-E; X40. D. In DM group, we also observed
remarkable perinuclear vacuolization (arrows) in myocytes and hemorrhagic area (star). H-E; X40. E. Common inflammatory cells
(arrows) were detected in DM group. H-E; X40. F. In some areas, loss of myofibril was observed in DM group. H-E; X40. G-H.
In DM + Crocin group, histopathological changes decreased. H-E; X40.
Previous studies indicated that crocin treatment after STZ administration of rats ameliorated remarkably the elevated levels of GSH, as
well as the decrease of lipid profiles and oxidative stress parameters, MDA, compared with untreated diabetic rats in plasma and heart tissue.
These results were supported by other researchers using saffron and crocin, which recovered from oxidative damage via diabetes in rats (Plants
and Karaj, 2009). We observed that these results are confirmed by variety of researches in which saffron, crocin, crocetin and safranal have
protective effects against oxidative damage in the STZ diabetic rats by scavenging free radicalls (Samarghandian et al., 2013).
Oxidative stress has an important role in the pathogenesis of both types of DM and the complications of diabetes (Kanter et al., 2004).
Hyperglycemia leads to increase in the formation of free radicals and impair antioxidant defense systems, which give support to diabetic
complications (Maritim et al., 2003b).
Clinical complications of diabetes could be prevented by reducing blood glucose level, but it is not only adequate for preventing
complications. Therefore, alternative treatment methods for diabetes must be developed (Control and Group, 1994). Maritim et al. demonstrated
that elevated oxidative stress caused to restrict the antioxidant defence systems in patients with DM, which might lead to insulin resistance and
contribute to the development of diabetes and its complications (Maritim et al., 2003a). Accordingly, amelioration of oxidative stress by
treatment with antioxidants could be an important strategy for preventing the initiation and progression of long term diabetic complications.
Furthermore, insulin resistance, which results in adipocyte dysfunction, is characterized by excessive rates of lipolysis and the release of free
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fatty acids (FFAs) into the plasma (McGarry, 2002). Elevated FFAs in the plasma lead to insulin resistance of hepatic and skeletal muscle and
increase of hepatic triglycerides in healty individuals (Kelley and Mandarino, 2000). The elevated hepatic triglyceride causes to increase
formation of more atherogenic LDL. These results may be the mechanisn of STZ-induced complications (SHAHADY, 2009).
GSH protects the tissues from oxidative damage by scavenging free radicals directly. It is also a cosubsrate for GSH-Px and a major
intracellular redox system. MDA is the most important and studied parameter relating to lipid peroxidation in many deseaes in recent years.
MDA is used to evaluate the severity of lipid peroxidation, releasing the toxic effect of ROS, which oxidize unsaturated fatty acids in the cell
membrane (Burton et al., 1984).
Dyslipidemia is defined as a disorder of lipoprotein metabolism, including lipoprotein overproduction or deficiency. Dyslipidemia may
be manifested by increase of total cholesterol, LDL and TG concentrations, and decrease of HDL concentration in the blood.
After diabetic rats treated with crocin in the present study, we observed that GSH levels increased significantly both serum and heart
tissue. In contrast, MDA levels decreased remarkably in serum and heart tissue. Also, total cholesterol, LDL and TG concentrations decreased
remarkably, accompanied by an increase HDL levels in serum.
The results of Samarghandian et al. are confirmed by the present study (Samarghandian et al., 2013). They observed that the significant
elevation in the blood glucose, MDA, nitric axide (NO), total lipids, TG, cholesterol and reduction of GSH level, CAT and SOD activity were
improved in the safranal–treated diabetic groups compared with the untreated groups, in a dose dependent manner. Our results also supported by
previous studies in which saffron, crocin, crocetin and safranal had protective effects against oxidative stress due to their antioxidant proporties
(Xi et al., 2007).
Anti-hyperglycemic effect of saffron may be manifested by mechanism including stimulation of glucose uptake, improvement of
insulin resistance, modulation of β-cells in pancreas to release more insulin and recovery of β-cells (Elgazar et al., 2013). According to these 
results, the protective effect of saffron on diabetic rats may occur due to its major ingredients, crocin, crocetin and safranal. These compounds
might be important in modulating insulin secretion and insulin resistance and preventing diabetes complications (Plants and Karaj, 2011).
Saffron extract and its ingredients have hypolipidemic effects by modulating oxidant/antioxidant system and inhibiting pancreatic
lipase activity as a competitive inhibitor (Sheng et al., 2006). Xu et al (2005) demonstrated that crocin decreased the levels of blood cholesterol,
TG and LDL and increased the level of HDL in hyperlipidemic rats, feeding heavy cholesterol diet in 2 months. In addition, Samarghandian et al
indicated that safranal decreased high lipid levels by modulating oxidative and nitrosive systems (Samarghandian et al., 2013). These results
agreed with the present study in which crocin decreased significantly elevation of the serum lipid levels and increased the level of HDL in
diabetic rats. Our findings also were comfirmed by Shirali et al (Shirali et al., 2013). They indicated that crocin decreased TG, total cholesterol
and LDL and elevated HDL in diabetic rats by improving insulin resistance.
The formation of ROS may lead to oxidative stress and influence the pathogenesis of myocardial infarction (Sawyer et al., 2002). ROS
include free radicals such as superoxide hydroxyl, peroxyl, hydroperoxyl as well as non-radical species such as hydrogen peroxide and
hydrochlorous acid (Evans et al., 2002). When lipids react with ROS, they turn into lipids peroxides. Lipid peroxides generate several products
including MDA (Raghuvanshi et al., 2007).
ROS can oxidize LDL to form ox-LDL, which is not recognized by the LDL receptor. Johansen et al reported that these oxidized lipid
products could bind to specific receptor proteins or activate inflammatory proteins which produce ROS (Johansen et al., 2005). Oxidative stress
plays a major role in onset of atherosclerosis. When ox-LDLs increase in blood, they can be taken into macrophages by scavenger receptors
resulting in the formation of foem cell and atherosclerotic plaques (Boullier et al., 2001). The migration of ox-LDLs in vascular wall is the main
reason of atherosclerosis. Saffron and its constituents can be effective on treatment of atherosclerosis by modulating lipid profiles through
improvement insulin resistance, oxidant-antioxidant system and inhibition of pancreatic lipase. Furthermore, it was showed that crocetin could
also prevent diabetes induced vascular complications by inhibition adhesion of leukocytes to the vascular wall (Xiang et al., 2006a).
In the present study, we observed several histopathological changes such as extensive hemorrhagic areas, cytoplasmic and perinuclear
myocardial vacuolization and inflammation were found in the heart tissue of diabetic rats, but crocin treatment ameliorated heart tissue damages.
Previous studies have also reported similar histopathological alterations in STZ-induced cardiac damage (Jain et al., 2010). On the other hand, in
our study, crocin reduced these changes and had a therapeutic effect in diabetic cardiac damage. Jain et al. (Jain et al., 2010) reported that Aloe
vera gel treated congestion and hemorrhage in diabetic cardiac damage. Yu et al. (Yu et al., 2013) reported that histopathological changes treated
with curcumin. Dobrzynski et al. (Dobrzynski et al., 2002) found that adrenomedullin reduced glygocen accumulation in rat heart. To our
knowledge, a study about available effects of crocin on STZ-induced cardiac damage in literature was not found.
The findings of one study indicated that saffranal could reduce lipid peroxidation and histopathologic changes in isoproterenol-induced
myocardial infarction in rats (Roya et al., 2011). Samarghandian et al. also demonstrated that safranal could prevent the formation of
atherosclerosis by decreasing serum NO level (Samarghandian et al., 2013).
Conclusıon
The present study demonsrated that treatment of diabetic rats with crocin ameliorated histopatholagical damages in heart tissue and
decreased MDA levels, accompanied by significant increase in GSH contents both serum and heart tissue. Crocin also could reduce elevated
lipid profiles in serum. Our results showed that crocin might prevent diabetes induced cardiovascular complication by reduction of oxidative
stress and dyslipidemia. These results support the potantiel efficacy of crocin for diabetes management.
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